Details of the Drug

General Information of Drug (ID: DMBLHIS)

• Drug Name: Ofranergene obadenovec
• Synonyms: VB-111

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 3	[1]
Glioblastoma of brain	2A00.00	Phase 2	[2]

• Drug Type: Gene therapy
• Cross-matching ID:
  UNII: 5Q5PRH05GI
  DrugBank ID: DB15175
  TTD ID: DU60ND
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03398655) A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT04406272) VB-111 in Surgically Accessible Recurrent/Progressive GBM. U.S. National Institutes of Health.